Participants from the placebo crossover group in Part 2 of Study SRP-9001-102 , scored 2.0 points higher on the mean North Star Ambulatory Assessment (NSAA) 48 weeks after treatment with SRP-9001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback